Non-traditional therapies are used to relieve pain in as many as 50 percent of hospitalized patients, offers a study in the Journal of Patient Safety. The study shows that an integrative program can have a significant impact on pain in an environment where pain management continues to be a major challenge, and traditional medications can have negative consequences.
“Roughly 80 percent of patients report moderate to severe pain levels after surgery,” says Gregory Plotnikoff, M.D., one of the study's authors and medical director of the Penny George Institute for Health and Healing at Abbott Northwestern Hospital. “We struggle to provide effective pain control while trying to avoid the adverse effects of opioid medications, such as respiratory depression, nausea, constipation, dizziness and falls.”
The study included 1,837 cardiovascular, medical, surgical, orthopedics, spine, rehabilitation, oncology, and women's health patients at Abbott Northwestern between January 1, 2008, and June 30, 2009. They scored their pain verbally on a zero-to-ten scale before and after treatments.
The treatments included non-pharmaceutical services, such as mind body therapies to elicit the relaxation response, acupuncture, acupressure, massage therapy, healing touch, music therapy, aromatherapy and reflexology. The study is entitled The Impact of Integrative Medicine on Pain Management in a Tertiary Care Hospital.
Jeffery A. Dusek, Ph.D., research director for the George Institute, adds, “Our real-world study broadly shows that these therapies effectively reduce pain by over 50 percent across numerous patient populations. Furthermore, they can be clinically implemented in real time, across, and under the operational and financial constraints within an acute care hospital.”
Dusek says future research will focus on defining appropriate intervention doses, duration of pain relief, and developing profiles of which patients are most likely to respond to non-pharmacologic treatments. Reductions in total hospitalization costs, medication use and adverse events will be quantified in future prospective research using the electronic medical record.